Giulia received her Bachelor’s degree in Medical and Molecular Biotechnology from the University of Verona in 2020, where she contributed to the development of a murine brain organoid system for disease modeling and pharmacological studies. After graduation, she began working on mitochondrial biology, using murine brain organoids to investigate the role of thyroid hormone in regulating mitochondrial metabolism during neurodevelopment. 

She completed her PhD in Neuroscience in 2025 at the University of Verona, participating in the European project CureMILS. Her doctoral research focused on evaluating PDE5 inhibitors as reference drugs for Leigh Syndrome, investigating their ability to normalize mitochondrial membrane potential (MMP) defects in neuroprogenitor cells carrying different ATP6 gene mutations, and elucidating their mechanisms of action on MMP and mitochondrial biogenesis. 

Since 2025, Giulia has been a Silverstein Fellow at the Institute of Biomedicine at Eurac Research (Bolzano), where she is investigating how GBA1 mutations disrupt cellular lipid homeostasis in Parkinson’s disease, with a specific emphasis on mitochondrial lipid alterations affecting cellular energy metabolism. 

Recognized for her curiosity, intelligence, and dedication, Giulia approaches research with both rigor and creativity. We wish her the very best for her future, confident that she will continue to achieve outstanding scientific contributions and inspire those around her.